Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

BACKGROUND: Ovarian cancer (OC) is considered the most lethal gynecological cancer, of which more than 65% cases are diagnosed in advanced stages, requiring platinum-based neoadjuvant chemotherapy (NACT). METHODS: A prospective-longitudinal study was conducted among women with advanced epithelial ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Alegría-Baños, Jorge A., Jiménez-López, José C., Vergara-Castañeda, Arely, de León, David F. Cantú, Mohar-Betancourt, Alejandro, Pérez-Montiel, Delia, Sánchez-Domínguez, Gisela, García-Villarejo, Mariana, Olivares-Pérez, César, Hernández-Constantino, Ángel, González-Santiago, Acitlalin, Clara-Altamirano, Miguel, Arela-Quispe, Liz, Prada-Ortega, Diddier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287739/
https://www.ncbi.nlm.nih.gov/pubmed/34275472
http://dx.doi.org/10.1186/s13048-021-00845-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287739/
https://www.ncbi.nlm.nih.gov/pubmed/34275472
http://dx.doi.org/10.1186/s13048-021-00845-6

Ejemplares similares